Skip to main content

Table 1 Baseline data

From: Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: a pilot study

 

All patients

No infection

Infection

p value

(n = 40)

(n = 19)

(n = 21)

Demographic data

 

 Age, median (IQR)

79.2 (70.4–82)

78.3 (74–80.5)

80.4 (69.5–83)

0.78

 Female sex, n (%)

18 (45)

9 (47.4)

9 (42.9)

1

Medical history, n (%)

    

 Hypertension

31 (77.5)

12 (63.2)

19 (90.5)

0.06

 Atrial fibrillation

9 (22.5)

3 (15.8)

6 (28.6)

0.17

 Current smoking

11 (27.5)

5 (26.3)

6 (28.6)

0.64

 Diabetes mellitus

7 (17.5)

4 (21.1)

3 (14.3)

0.69

 Coronary heart disease

10 (25)

4 (21.1)

6 (28.6)

0.72

 Previous stroke

11 (27.5)

5 (26.3)

6 (28.6)

1

Clinical data, median (IQR)

    

 NIHSS at admission

5.5 (2–12)

3 (2–7)

12 (4–14)

0.01

Laboratory values, median (IQR)

    

 WBC (g/l)

8.6 (6.8–10.1)

7.7 (6.2–9.3)

9.3 (7.4–11.2)

0.14

 CRP (mg/l)

3.6 (3–9.1)

3.6 (3–6.8)

4.8 (3–17.4)

0.22

Lesion size on MR, DWIb

    

 Small (1–10 mm3)

23 (27.5)

13 (68.4)

10 (47.6)

0.47

 Medium (10–100 mm3)

8 (20)

3 (15.8)

5 (23.8)

0.75

 Large (>100 mm3)

1 (2.5)

0 (0)

1 (4.8)

0.69

TOAST

    

 Large vessel stroke

8 (20)

3 (15.8)

 

0.69

 Cardioembolic stroke

8 (20)

4 (21.1)

 

1

 Microangipathic stroke

14 (35)

5 (26.3)

 

0.33

 Other

0 (0)

0 (0)

  

 Unknown

10 (25)

7 (36.8)

 

0.15